![](/assets/artwork/1x1-42817eea7ade52607a760cbee00d1495.gif)
100 episodes
![](/assets/artwork/1x1-42817eea7ade52607a760cbee00d1495.gif)
Psychopharmacology and Psychiatry Updates Psychopharmacology Institute
-
- Health & Fitness
Practical psychopharmacology updates for mental health clinicians. Useful for psychiatry / mental health professionals. Expert interviews and soundbites from CME presentations. Practical and free of commercial bias. Not sponsored by any pharmaceutical company.
-
Balancing Benefits and Risks: Antipsychotics in Hepatic Dysfunction
In this episode, we explore the safety of antipsychotics in patients with liver disease. How can psychiatrists navigate the risk–benefit balance when treating medically complex individuals? Dr. Sydney LeFay discusses key insights from a recent review article, guiding antipsychotic selection and monitoring.
Faculty: Sydney LeFay, D.O.
Host: Richard Seeber, M.D.
Learn more about our membership here Earn 0.75 CMEs: Quick Take Vol. 56 Antipsychotic Safety in Liver Disease -
Insomnia and Depression: A Tangled Web
In this episode, we explore the complex relationship between insomnia and major depressive disorder. How does insomnia impact the course and treatment of depression? Join us as we dive into the neurobiology and clinical implications of this fascinating topic with expert Dr. Amit Chopra.
Faculty: Amit Chopra, M.D.
Host: Richard Seeber, M.D.
Learn more about our memberships here Earn 1.25 CME: Navigating Insomnia in Major Depressive Disorder: Advances in Management Understanding the Relationship Between Insomnia Disorder and MDD -
ADHD Treatment During Pregnancy: Insights from Denmark
In this episode, we explore the long-term effects of ADHD medication use during pregnancy on children's development. Can continuing treatment pose risks, or is it safer than previously thought? Join us as we dive into a groundbreaking Danish study that sheds light on this critical question.
Faculty: David Rosenberg, M.D.
Host: Richard Seeber, M.D.
Learn more about our membership here Earn 0.5 CMEs: CAP Smart Takes Vol. 16 In Utero Exposure to ADHD Medication and Long-Term Offspring Outcomes -
The Power of Nonpharmacologic Therapies in Fibromyalgia
In this episode, we explore the growing evidence for nonpharmacologic therapies in managing fibromyalgia symptoms. Could a combination of exercise, cognitive–behavioral therapy, and integrative approaches, like acupuncture or yoga, be the key to better outcomes for patients resistant to traditional treatments?
Faculty: Daniel Clauw, M.D.
Host: Richard Seeber, M.D.
Learn more about our memberships here Earn 0.75 CME: Nociplastic Pain Syndromes: Focus on Fibromyalgia Nonpharmacologic Therapies for Fibromyalgia -
Highlights From APA 2024: Key Insights on Psychopharmacology
In this episode, the editorial team of the Psychopharmacology Institute discusses 3 important topics presented at the APA Annual Meeting: Prescribing psychiatric medications during pregnancy, recent advances in clozapine treatment, and managing eating disorders, namely anorexia nervosa and bulimia nervosa. The episode covers the safety and dose adjustments for medications like SSRIs, lamotrigine, and lithium during pregnancy; early initiation and monitoring of clozapine; and effective treatments, including psychotherapy, olanzapine, and fluoxetine for eating disorders.
Hosts: Flavio Guzman, M.D., Paz Badia, M.D., and Lorena Rodriguez, M.D.
-
Antidepressants in Pregnancy: Weighing the Evidence
In this episode, we discuss a new study on maternal depression, antidepressant use, and pregnancy complications. Can antidepressants during pregnancy harm the baby? Dr. Lauren Osborne helps us weigh the risks and benefits.
Faculty: Lauren Osborne, M.D.
Host: Richard Seeber, M.D.
Learn more about our membership here Earn 0.5 CMEs: Quick Take Vol. 56 Neonatal and Pregnancy Complications Following Maternal Depression or Antidepressant Exposure